Published in Cancer Weekly, July 24th, 2007
Dr. Hulse also is a member of the Board of Directors at Battelle, a $3 billion annual revenue global science and technology enterprise that develops and commercializes technology and manages laboratories for customers.
"Although...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-07-24)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.